Optimising exits in an environment where liquidity is challenging has become a mainstay in some managers’ playbooks.

Private equity-backed insurer CFC is eyeing a £5billion London listing – lifting a market which has suffered a mass exodus.

EQT X to acquire Adalvo, a rapidly growing, asset-light B2B dossier developer providing market-approval-ready generic drug dossiers to ph ...

With second-quarter earnings underway, here is a compilation of dividends and distributions declared from select upstream, ...

IndoStar Capital Finance Limited today announced that it has completed the transaction to sell its wholly owned subsidiary ...

EQT Corporation EQT is set to report second-quarter 2025 results on July 22, after the closing bell. In the last reported ...

CFC is exploring options including listing on the London Stock Exchange, according to the Financial Times. The article put ...

The buyer, U.S. PE firm Advent, was recently outbid by KKR in its pursuit of another Slaughter and May client, Spectris.

Concord Biotech Limited has announced the successful completion of the European Union Good Manufacturing Practice (EU GMP) ...